Start Your Search

Vess Stamenova



Author of

  • +

    OS08 - The Road to Digital Health Adoption (ID 12)

    • Event: e-Health 2019 Virtual Meeting
    • Type: Oral Session
    • Track: Health Business Process
    • Presentations: 1
    • Coordinates: 5/27/2019, 03:30 PM - 04:30 PM, Pod 7
    • +

      OS08.02 - Co-Designing Digital Technology Evaluations with Service Providers, Vendors and Evaluators (ID 421)

      Vess Stamenova, Toronto/CA

      • Abstract
      • Slides

      Purpose/Objectives:
      The Office of the Chief Health Innovation Strategist (OCHIS) in Ontario supports a program called Health Technologies Fund (HTF). The program?s goal is to accelerate the evaluation, procurement, adoption and diffusion of health technologies made in Ontario. The program requires a partnership between publicly funded health service providers (HSPs), a technology vendor and a third-party evaluator. This partnership ensures that technology companies are supported in an implementation initiative within an Ontario clinical context by working closely with a clinical site that has an interest in the technology. The evaluation partner?s role is to conduct an evaluation that can support procurement decisions at the clinical site and provide evidence of effectiveness and potential cost-savings. The Women?s College Hospital Institute for Health System Solutions and Virtual Care (WIHV) has acted as an evaluation partner for three rounds of HTF competitions. The goal of this panel will be to present key learning points from the perspective of each partner: the HSP, the technology partner and the evaluation partner. The key learnings will be presented in the context of one of our projects, the evaluation of the Cloud Dx Health Kit.


      Methodology/Approach:
      The Cloud Dx Health Kit is a web-enabled remote- and self-monitoring platform allowing Chronic Obstructive Pulmonary Disease (COPD) patients to take their vital signs (oxygen saturation, blood pressure, temperature, and weight). Data is displayed on the tablet via Bluetooth and sent to a healthcare provider via a secure cloud. To determine and ensure that all participating parties? interests are being met in the project design, we spent several months co-designing the project. The goals during this phase were to design a viable implementation plan that will have a high likelihood of adoption within the specific setting. Weekly calls between the vendor (Cloud Dx), the HSP (Markham Stouffville Hospital) and the evaluator (WIHV) were conducted. Several in-person meetings and half day co-design workshops were completed to establish viable value-proposition hypotheses and to determine each party?s interests. Qualitative interviews with patients, healthcare providers and administrators were also conducted, to test out value proposition hypotheses. The level of commitment of the vendor company and their capacity for technology modifications was also assessed at that time. Feedback received from users and administrators was directly used to make modification of the implementation plan and research study design.


      Finding/Results:
      The following key insights were gained from the above process (1) an on-site clinical lead is essential, (2) the development of relationships between all three parties facilitate progress, (3) allowing end-users to use the technology can uncover critical workflow and technology modifications that need to be well established ahead of the evaluation and (4) determining the value propositions for both users and payers is critical for adoption.


      Conclusion/Implications/Recommendations:
      In this panel discussion, we are going to provide an overview of the co-design methods we use in the planning and design of our evaluations. Representatives from each team will describe the challenges they faced in running such collaborative projects and present key learnings focused on implementation and evaluation of digital technologies.


      140 Character Summary:
      This panel will provide an overview and perspectives on a co-designing evaluations with vendors, clinical providers and evaluators.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.